IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?

Established pharmaceutical giants have delivered lower volatility and higher income than clinical-stage biotech exposure over ...

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to ...
The Motley Fool

Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging

JAAA: $46.41 million (5.7% of AUM) VUG: $40.11 million (4.9% of AUM) DFLV: $32.03 million (3.9% of AUM) JCPB: $28.13 million (3.45% of AUM) AMZN: $27.70 million (3.4% of AUM) As of Tuesday afternoon, ...
Nasdaq

Interesting IBB Put And Call Options For December 19th

Investors in iShares Trust - iShares Biotechnology ETF (Symbol: IBB) saw new options begin trading today, for the December 19th expiration. One of the key data points that goes into the price an ...
Nasdaq

Should You Invest in the iShares Biotechnology ETF (IBB)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund ...